Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant SARS-CoV-2 Nucleocapsid anticorps (Biotin)

L’anticorps Souris Chimeric anti-SARS-CoV-2 Nucleocapsid a été validé pour ELISA. Il convient pour détecter SARS-CoV-2 Nucleocapsid dans des échantillons de SARS Coronavirus-2 (SARS-CoV-2).
N° du produit ABIN7273318

Aperçu rapide pour Recombinant SARS-CoV-2 Nucleocapsid anticorps (Biotin) (ABIN7273318)

Antigène

Voir toutes SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) Anticorps
SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)

Type d'anticorp

Recombinant Antibody

Reactivité

  • 72
  • 10
  • 4
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SARS Coronavirus-2 (SARS-CoV-2)

Hôte

  • 33
  • 28
  • 17
  • 3
  • 1
  • 1
Souris

Clonalité

  • 63
  • 15
  • 4
Chimeric

Conjugué

  • 67
  • 10
  • 4
  • 1
Cet anticorp SARS-CoV-2 Nucleocapsid est conjugé à/à la Biotin

Application

  • 72
  • 39
  • 11
  • 9
  • 7
  • 7
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA

Classe de qualité

MALS verified

Clone

AM223
  • Fonction

    Biotinylated Anti-SARS-CoV-2 Nucleocapsid Antibody, Chimeric mAb, Human IgG1 (AM223) (MALS verified)

    Specificité

    This product can recognize SARS-CoV-2 nucleocapsid protein. No cross-reactivity is detected with nucleocapsid protein of other coronaviruses, including MERS-CoV, HCoV-229E, HCoV-NL63, HCoV-OC43 and HCoV-HKU1.

    Attributs du produit

    Recombinant Antibodies produced in HEK293. Biotinylated Anti-SARS-CoV-2 Nucleocapsid Antibody, Chimeric mAb, Human IgG1 (AM223) is a chimeric monoclonal antibody recombinantly expressed from HEK293 cells, which combines the variable region of a mouse monoclonal antibody with human IgG1 constant domain. The mouse monoclonal antibody was obtained from a mouse immunized with recombinant SARS-CoV-2 Nucleocapsid Protein. This chimeric antibody is purified by Protein A affinity chromatography.

    Immunogène

    Biotinylated Anti-SARS-CoV-2 Nucleocapsid Antibody, Chimeric mAb, Human IgG1 (AM223) is a chimeric monoclonal antibody recombinantly expressed from HEK293 cells, which combines the variable region of a mouse monoclonal antibody with human IgG1 constant domain. The mouse monoclonal antibody was obtained from a mouse immunized with recombinant SARS-CoV-2 Nucleocapsid Protein. This chimeric antibody is purified by Protein A affinity chromatography.

    Isotype

    IgG1
  • Indications d'application

    This antibody can be paired with other Anti-SARS-CoV-2 Nucleocapsid antibodies to detect SARS-CoV-2 Nucleocapsid protein in sandwich ELISA or LFA assay.

    Commentaires

    A chemically labeled biotinylated protein with ultra sensitivity.
    The product is produced using a chemical labeling approach. The primary amines in the side chains of lysine residues and the N-terminus of protein are conjugated with biotins.
    Chemical labeling usually results in multiple biotin attachment on a single protein molecule, which could potentially lead to higher detection sensitivity.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Stock

    -80 °C

    Stockage commentaire

    -70°C
  • Antigène

    SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)

    Autre désignation

    SARS-CoV-2 Nucleocapsid protein

    Sujet

    Nucleocapsid (N) protein is the most abundant protein found in coronavirus. CoV N protein is a highly immunogenic phosphoprotein important for viral genome replication and modulation of cell signaling pathways. It was first identified by a research team while they were screening for ADP-ribosylated proteins during coronavirus (CoV) infection (Grunewald M. E., et al. 2017, Virology, 517: 62-68). The array of diverse functional activities accommodated in N protein makes it more than a structural protein but also an interesting target in the development of antiviral therapeutics. Because of the conservation of N protein sequence and its strong immunogenicity, N protein of coronavirus is chosen as a diagnostic tool.
Vous êtes ici:
Chat with us!